Editas, a biotech company, is funding Broad's legal fees [1]. I had thought that...

greeneggs on April 16, 2017 | parent | context | favorite | on: Why the University of California Is Appealing the ...

Editas, a biotech company, is funding Broad's legal fees [1]. I had thought that another startup was funding Berkeley's side, but am having trouble finding a source.

[1] http://www.sciencemag.org/news/2017/02/how-battle-lines-over...